Oramed Pharma (ORMP)
4.12
+0.15 (3.78%)
Upcoming Events
Latest Headlines
Lifeward raises $5.6M in convertible notes with $5.6M more tied to milestones
July 7, 2026 4:15 PM - StreetInsider
Lifeward Secures Growth Capital to Accelerate Commercial Expansion with Up to $11.2 Million in Strategic Financing
July 7, 2026 4:15 PM - StreetInsider
Form 4 ORAMED PHARMACEUTICALS For: Jul 01 Filed by: Hexter Joshua
July 2, 2026 5:00 PM - SEC Filing
Form 4 ORAMED PHARMACEUTICALS For: Jul 01 Filed by: Gabay Avraham
July 2, 2026 5:00 PM - SEC Filing
Form 144 ORAMED PHARMACEUTICALS Filed by: Hexter Joshua
July 1, 2026 12:03 PM - SEC Filing
Form 144 ORAMED PHARMACEUTICALS Filed by: Gabay Avraham
July 1, 2026 11:47 AM - SEC Filing
Form 8-K ORAMED PHARMACEUTICALS For: Jun 25
June 30, 2026 4:19 PM - SEC Filing
Form SCHEDULE 13G/A ORAMED PHARMACEUTICALS Filed by: BML Investment Partners, L.P.
June 29, 2026 10:34 AM - SEC Filing
Oramed to join Russell indexes amid $270M balance sheet
June 25, 2026 11:35 AM - StreetInsider
Oramed Releases Letter to Shareholders, Highlighting Russell 2000/3000 Index Inclusion, Scilex Loan Repayment, Strategic Portfolio Appreciation, and a Strengthened Balance Sheet
June 25, 2026 11:35 AM - PR NewsWire
Oramed Pharmaceuticals set to join Russell 2000 and 3000 indexes
June 17, 2026 8:55 AM - StreetInsider
Oramed Pharmaceuticals to Join Russell 2000® and Russell 3000® Indexes
June 17, 2026 8:55 AM - PR NewsWire
Form 10-Q ORAMED PHARMACEUTICALS For: Mar 31
May 19, 2026 5:08 PM - SEC Filing
Form NT 10-Q ORAMED PHARMACEUTICALS For: Mar 31
May 15, 2026 4:10 PM - SEC Filing
Form SCHEDULE 13G ORAMED PHARMACEUTICALS Filed by: Aquamarine Financial (Cayman) Ltd
May 15, 2026 12:07 PM - SEC Filing
Full Article List
